Holen Sie sich die Stockscreener-App
10.86
3.79%
0.38
Ardent Health Inc Aktie (ARDT) Neueste Nachrichten
Ardent Health (NYSE: ARDT) ex-exec lines up six-figure stock sale - Stock Titan
Ardent Health’s BSA Health System partners with Cardiology Center of Amarillo to expand heart care access - Bitget
Ardent Health (NYSE: ARDT) ex-exec lines up 2026 sale of stock grants - Stock Titan
Sei Investments Co. Lowers Stock Holdings in Ardent Health, Inc. $ARDT - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Encourages Ardent Health, Inc. (ARDT) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
2026-08-16 | Bronstein, Gewirtz & Grossman, LLC Encourages Ardent Health, Inc. (ARDT) Stockholders to Inquire about Securities Investigation | NYSE:ARDT | Press Release - Stockhouse
ARDT Q2 2026 Earnings: EPS Misses Estimates by 35.06% as Stock DeclinesFinal Results - Vinanet
Why Ardent Health (ARDT) Is Down 5.5% After Cutting 2026 Guidance And Fueling Options JittersAnd What's Next - simplywall.st
Wedge Capital Management L L P NC Acquires 222,447 Shares of Ardent Health, Inc. $ARDT - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Ardent Health, Inc. (ARDT) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Implied Volatility Surging for Ardent Health Stock Options - TradingView
Ardent Health, Inc. (ARDT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Ardent Health (ARDT) Q2 2026 Earnings Call Transcript - The Globe and Mail
ARDT WRITE OFFS: Hagens Berman Investigating Claims Against Ardent Health (ARDT) Over Alleged $97M Accounting Shock and "180-Day Cliff" Reserves (PR Newswire) - Aktiellt
A next-generation heart pump is tested during high-risk stenting - Stock Titan
Ardent Health, Inc. (ARDT) Stock Analysis: Exploring a 13.84% Potential Upside for Investors - DirectorsTalk Interviews
Ardent Health (ARDT) Falls 4.24% to $11.06, Approaches Key $10.51 SupportSynthetic Long - Vinanet
RBC Capital raises Ardent Health stock price target on EBITDA beat By Investing.com - Investing.com Australia
RBC Capital raises Ardent Health stock price target on EBITDA beat - Investing.com India
Ardent Moves on From Managers, Bumps Cost-Cutting Plan to $70M+ - HCI Innovation Group
RBC Adjusts PT on Ardent Health Partners to $13 From $12, Maintains Outperform Rating - marketscreener.com
Goldman Sachs Maintains Ardent Health(ARDT.US) With Hold Rating, Maintains Target Price $13 - Moomoo
Bronstein, Gewirtz & Grossman, LLC Is Investigating Ardent Health, Inc. (ARDT) And Encourages Investors to Connect - ACCESS Newswire
ARDT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law Review
Ardent Health (NYSE:ARDT) Rating Lowered to Strong Sell at Zacks Research - MarketBeat
Is Ardent Health (ARDT) Cheap On Lowered Guidance And Weaker Q2 Earnings? - Yahoo Finance
A Quick Look at Today's Ratings for Ardent Health(ARDT.US), With a Forecast Between $12 to $13 - Moomoo
New Strong Sell Stocks for August 7th - The Globe and Mail
Ardent Health, Inc. (NYSE:ARDT) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
Guggenheim raises Ardent Health stock price target on EBITDA beat By Investing.com - Investing.com India
Ardent Health (NYSE:ARDT) Stock Price Expected to Rise, Truist Financial Analyst Says - MarketBeat
Guggenheim raises Ardent Health stock price target on EBITDA beat - Investing.com
A Quick Look at Today's Ratings for Ardent Health(ARDT.US), With a Forecast Between $9 to $14 - Moomoo
Truist Adjusts Price Target on Ardent Health Partners to $13 From $12, Maintains Buy Rating - Moomoo
Ardent Health Inc (ARDT) (Q2 2026) Earnings Call Highlights: Raising Impact Program Savings ... - Yahoo Finance UK
Ardent Health Q2 Earnings Call Highlights - TradingView
Earnings call transcript: Ardent Health Q2 2026 EPS misses as stock rises 8% - Investing.com Canada
Bronstein, Gewirtz & Grossman, LLC Encourages Ardent Health, Inc. (ARDT) Investors to Inquire about Securities Investigation - ACCESS Newswire
ARDT: Q2 results beat expectations with strong cost controls and reaffirmed 2026 guidance - TradingView
Bronstein, Gewirtz & Grossman, LLC Encourages Ardent Health, Inc - The National Law Review
Ardent Health Partners, LLC Q2 2026 Earnings Call Summary - Yahoo Finance
Why Ardent Health (ARDT) Is Down 6.3% After Cutting 2026 Earnings Guidance On Weaker Q2 Results - simplywall.st
First Trust Advisors LP Buys 198,595 Shares of Ardent Health, Inc. $ARDT - MarketBeat
Ardent Health Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Ardent Health, Inc. (ARDT) Q2 Earnings Lag Estimates - Yahoo Finance
ARDT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law Review
Ardent Health, Inc. (ARDT) Releases Q2 2026 Earnings: EPS Miss and Profitability Declines - Quiver Quantitative
Earnings Flash (ARDT) Ardent Health, Inc. Reports Q2 Revenue $1.62B, vs. FactSet Est of $1.59B - marketscreener.com
Ardent Health reports Q2 2026: $1.62B revenue, $17M net income, $115M adjusted EBITDA - TradingView
Tranche Update on Ardent Health, Inc.'s Equity Buyback Plan announced on November 18, 2025. - marketscreener.com
Ardent Health Reports Second Quarter 2026 Results - Business Wire
Ardent Health Inc (ARDT) Q2 2026 Earnings Report Preview: What To Look For - Yahoo Finance
Ardent Health Q2 FY26 net income drops 76.84% to $17 million; revenue slips 1.4% to $1.62 billion - Bitget
Ardent Health, Inc. (ARDT) Stock Analysis: Evaluating the 12.05% Potential Upside for Healthcare Investors - DirectorsTalk Interviews
Ardent Health (NYSE:ARDT) Issues Earnings Results - MarketBeat
1.30%
1.92%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):